Related references
Note: Only part of the references are listed.Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort
Ricardo Ataide et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial
Aung Pyae Phyo et al.
LANCET INFECTIOUS DISEASES (2016)
Intramuscular Artesunate for Severe Malaria in African Children: A Multicenter Randomized Controlled Trial
Peter G. Kremsner et al.
PLOS MEDICINE (2016)
Quantifying the pharmacology of antimalarial drug combination therapy
Ian M. Hastings et al.
SCIENTIFIC REPORTS (2016)
How Robust Are Malaria Parasite Clearance Rates as Indicators of Drug Effectiveness and Resistance?
Ian M. Hastings et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Altering Antimalarial Drug Regimens May Dramatically Enhance and Restore Drug Effectiveness
Katherine Kay et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Clinical determinants of early parasitological response to ACTs in African patients with uncomplicated falciparum malaria: a literature review and meta-analysis of individual patient data
Salim Abdulla et al.
BMC MEDICINE (2015)
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis
Salim Abdulla et al.
MALARIA JOURNAL (2015)
Targeting the Cell Stress Response of Plasmodium falciparum to Overcome Artemisinin Resistance
Con Dogovski et al.
PLOS BIOLOGY (2015)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Genetic Evaluation of the Performance of Malaria Parasite Clearance Rate Metrics
Standwell C. Nkhoma et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Reduced Susceptibility of Plasmodium falciparum to Artesunate in Southern Myanmar
Myat P. Kyaw et al.
PLOS ONE (2013)
Improving Pharmacokinetic-Pharmacodynamic Modeling to Investigate Anti-Infective Chemotherapy with Application to the Current Generation of Antimalarial Drugs
Katherine Kay et al.
PLOS COMPUTATIONAL BIOLOGY (2013)
Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
Debashish Das et al.
CLINICAL INFECTIOUS DISEASES (2012)
Intrahost modeling of artemisinin resistance in Plasmodium falciparum
Sompob Saralamba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Artemisinin Resistance in Cambodia: A Clinical Trial Designed to Address an Emerging Problem in Southeast Asia
Harald Noedl et al.
CLINICAL INFECTIOUS DISEASES (2010)
In Vivo Parasitological Measures of Artemisinin Susceptibility
Kasia Stepniewska et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Randomized controlled trial of artesunate or artemether in Vietnamese adults with severe falciparum malaria
Nguyen H. Phu et al.
MALARIA JOURNAL (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
Elizabeth A. Ashley et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
Semi-mechanistic pharmacokinetic/pharmacodynamic modelling of the antimalarial effect of artemisinin
T Gordi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2005)
A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria
EA Ashley et al.
CLINICAL INFECTIOUS DISEASES (2005)
Artesunate-clindamycin versus quinine-clindamycin in the treatment of Plasmodium falciparum malaria:: A randomized controlled trial
M Ramharter et al.
CLINICAL INFECTIOUS DISEASES (2005)
Share Paper
